Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards an Individually Tailored Enzyme Replacement Therapy in Pompe Disease: A Controlled Study for Elucidation of Molecular Structures Contributing to Enzyme Uptake and Immunoreactivity

NCT05448131 is registered in ClinicalTrials.gov with Centre for Analytical Biochemistry and Biomedical Mass Spectrometry as lead sponsor.

NCT NCT05448131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05448131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards an Individually Tailored Enzyme Replacement Therapy in Pompe Disease: A Controlled Study for Elucidation of Molecular Structures Contributing to Enzyme Uptake and Immunoreactivity
Lead sponsor
Centre for Analytical Biochemistry and Biomedical Mass Spectrometry
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2023
Completion date
October 7, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pompe-disease